© 2019  by Bria Fund ™ Supporters for FIP Research

  • Black Facebook Icon
  • Black Twitter Icon

April 11, 2019

This article is about contaminated generics, but we think it explains and justifies some of FIP Fighters’ concerns about use of unapproved substances and drugs. Please read it thoroughly and carefully. It explains that generics are not the same as or identical to name brand drugs. Contamination problems were caused by active pharmaceutical ingredients manufactured in China and India. There are still manufacturing problems in those countries, and the FDA has stepped up its presence and manufacturing inspections in both countries.

Drugs alleging to be GC376 and GS441524 are not generic versions of the drugs in the clinical trials, nor have their safety and efficacy been established.

Susan Gingrich

Article from MSN.com

...

August 15, 2018

CAUTION!

Increased FIP research is important and needed, but an important reminder! We need to ensure published research is from a credible source. Legitimate FIP research is peer reviewed and accepted by research experts involved in the publication it appears in. Once accepted and published in a credible publication, news of it is widely shared. The process of acceptance and publication can be quite difficult at times. It often requires additional information and resubmission, until accepted. Dr. Pedersen is in the process of submitting Luna's clinical trial for publication. Despite it not being published, including the trial’s protocol, and the exact formula of the drug proprietary, (totally the private property of...

Please reload

RSS Feed
RSS Subscribe
Featured Posts

Contaminated Generic Drugs

1/7
Please reload

Categories
Please reload

Search By Tags
Please reload

Archive
Please reload